ARCHIVES

The Cancer Letter takes two-week break; next issue Jan. 2.

This article is from The Cancer Letter archive.

Vol. 29 No. 46 | December 12, 2003

Download PDF Visit The Full Archive

Related Articles

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

Science Agencies Seek To Measure Effect Of Research Funding

June 4, 2010

“Bring Contracts Under Control, Save $100,00 A Year,” Samuels Tells NCI

November 2, 1979

Court Upholds FDA Position On Definition Of A Drug.

February 23, 2001

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012

Protocols Approved During The Month of September 2001

October 26, 2001